Syremis Therapeutics is based in Petah Tikva, Israel. It has raised $165M in total funding. Latest round: Series A.
Syremis Therapeutics is based in Petah Tikva, Israel. Syremis Therapeutics has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Syremis Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Dexcel Pharma, Third Rock Ventures, Bain Capital Life Sciences, GV (Google Ventures), QVT Financial LP, Pictet Group. 6 distinct backers are named across the disclosed rounds.
We update the Syremis Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Petah Tikva and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026